Onderneming Hinova Pharmaceuticals Inc.
Aandelen
688302
CNE1000059F5
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30 CNY | -1,48% | +3,16% | -42,39% |
Vakgebied
Aantal werknemers: 181
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xing Hai Li
FOU | Founder | 61 | 05-02-13 |
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 05-02-13 |
Ze Yan Shi
DFI | Director of Finance/CFO | 43 | 12-11-21 |
Guo Hong
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-23 |
Dai Li
COO | Chief Operating Officer | 43 | 21-09-20 |
Xia Li
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 05-02-13 |
Xing Hai Li
FOU | Founder | 61 | 05-02-13 |
Yuan Lun Chen
BRD | Director/Board Member | 54 | 21-09-20 |
Dai Li
COO | Chief Operating Officer | 43 | 21-09-20 |
Ya Guang Zheng
BRD | Director/Board Member | 53 | 15-09-23 |
Yu Quan Wei
BRD | Director/Board Member | 65 | 21-09-20 |
Yong Chen Peng
BRD | Director/Board Member | 71 | 21-09-20 |
Hong Qun Ma
BRD | Director/Board Member | 41 | 15-09-23 |
Wen Li
BRD | Director/Board Member | 40 | 15-09-23 |
Jian Hong Lan
CHM | Chairman | 40 | 21-09-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 99 015 598 | 58 691 836 ( 59,28 %) | 0 | 59,28 % |
Bedrijfsgegevens
Hinova Pharmaceuticals, Inc.
4/F, Bldg 1, No. 2-3, Rongyao Bldg 5 Keyuan South Road
610041, Chengdu
+
http://www.hinovapharma.comSector
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,39% | 411 mln. | |
+24,31% | 46,71 mld. | |
+48,83% | 41,8 mld. | |
-1,21% | 41,52 mld. | |
-3,42% | 29,55 mld. | |
+10,84% | 25,78 mld. | |
-21,25% | 19,26 mld. | |
+0,53% | 12,14 mld. | |
-3,35% | 12,08 mld. | |
+26,84% | 11,98 mld. |
- Beurs
- Aandelen
- Koers 688302
- Onderneming Hinova Pharmaceuticals Inc.